- Home
- CSGS vs LBPH Comparison
CSGS vs LBPH Comparison
Compare CSGS & LBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGS
- LBPH
- Stock Information
- Founded
- CSGS 1994
- LBPH 2020
- Country
- CSGS United States
- LBPH United States
- Employees
- CSGS N/A
- LBPH N/A
- Industry
- CSGS EDP Services
- LBPH Biotechnology: Pharmaceutical Preparations
- Sector
- CSGS Technology
- LBPH Health Care
- Exchange
- CSGS Nasdaq
- LBPH Nasdaq
- Market Cap
- CSGS 1.6B
- LBPH 1.4B
- IPO Year
- CSGS 1996
- LBPH 2021
- Fundamental
- Price
- CSGS $54.48
- LBPH $59.69
- Analyst Decision
- CSGS Strong Buy
- LBPH Buy
- Analyst Count
- CSGS 5
- LBPH 8
- Target Price
- CSGS $61.60
- LBPH $52.29
- AVG Volume (30 Days)
- CSGS 252.0K
- LBPH 1.1M
- Earning Date
- CSGS 11-06-2024
- LBPH 11-07-2024
- Dividend Yield
- CSGS 2.20%
- LBPH N/A
- EPS Growth
- CSGS N/A
- LBPH N/A
- EPS
- CSGS 2.27
- LBPH N/A
- Revenue
- CSGS $1,177,920,000.00
- LBPH N/A
- Revenue This Year
- CSGS N/A
- LBPH N/A
- Revenue Next Year
- CSGS $3.97
- LBPH N/A
- P/E Ratio
- CSGS $23.97
- LBPH N/A
- Revenue Growth
- CSGS 1.39
- LBPH N/A
- 52 Week Low
- CSGS $39.56
- LBPH $3.60
- 52 Week High
- CSGS $57.16
- LBPH $59.95
- Technical
- Relative Strength Index (RSI)
- CSGS 67.66
- LBPH 79.25
- Support Level
- CSGS $55.22
- LBPH $59.71
- Resistance Level
- CSGS $56.70
- LBPH $59.87
- Average True Range (ATR)
- CSGS 1.65
- LBPH 0.23
- MACD
- CSGS 0.56
- LBPH -0.92
- Stochastic Oscillator
- CSGS 75.61
- LBPH 76.99
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from Americas (principally the U.S.).
About LBPH Longboard Pharmaceuticals Inc.
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.